IRF2-mediated upregulation of lncRNA HHAS1 facilitates the osteogenic differentiation of bone marrow-derived mesenchymal stem cells by acting as a competing endogenous RNA.
IRF2-mediated upregulation of lncRNA HHAS1 facilitates the osteogenic differentiation of bone marrow-derived mesenchymal stem cells by acting as a competing endogenous RNA.
复制标题
IRF2介导的lncRNA HHAS1作为竞争性内源RNA促进骨髓间充质干细胞的成骨分化
DOI:
10.1002/ctm2.429
复制
发表时间:
2021-06
影响因子:
10.6
通讯作者:
Shen H
中科院分区:
文献类型:
--
作者:
Ye G;Wang P;Xie Z;Li J;Zheng G;Liu W;Cao Q;Li M;Cen S;Li Z;Yu W;Wu Y;Shen H
Mesenchymal stem cells (MSCs) are the major source of osteoblasts. Long noncoding RNAs (lncRNAs) are abundantly expressed RNAs that lack protein‐coding potential and play an extensive regulatory role in cellular biological activities. However, the regulatory network of lncRNAs in MSC osteogenesis needs further investigation. QRT‐PCR, western blot, immunofluorescence, and immunohistochemistry assays were used to determine the levels of relevant genes. The osteogenic differentiation capability was evaluated by using Alizarin Red S (ARS) staining, alkaline phosphatase activity assays, hematoxylin & eosin staining or micro‐CT. RNA fluorescence in situ hybridization (FISH) and RNAscope were used to detect HHAS1 expression in cells and bone tissue. A microarray assay was performed to identify differentially expressed microRNAs. RNA immunoprecipitation and RNA pull‐down were used to explore the interactions between related proteins and nucleic acids. The level of lncRNA HHAS1 increased during bone marrow‐derived MSC (BMSC) osteogenesis and was positively related to the levels of osteogenic genes and ARS intensity. HHAS1 was located in both the cytoplasm and the nucleus and was expressed in human bone tissue. HHAS1 facilitated BMSC osteogenic differentiation by downregulating miR‐204‐5p expression and enhancing the level of RUNX family transcription factor 2 (RUNX2). In addition, interferon regulatory factor 2 (IRF2) was increased during BMSC osteogenic differentiation and interacted with the promoter of HHAS1, which resulted in the transcriptional activation of HHAS1. Furthermore, IRF2 and HHAS1 helped improve bone defect repair in vivo. Our study identified a novel lncRNA, HHAS1, that facilitates BMSC osteogenic differentiation and proposed a role for the IRF2/HHAS1/miR‐204‐5p/RUNX2 axis in BMSC osteogenesis regulation. These findings help elucidate the regulatory network of BMSC osteogenesis and provide potential targets for clinical application. Graphical Highlights 1. Under the condition of osteogenic induction, the level of IRF2 is increased and promotes the transcription of lncRNA HHAS1. 2. HHAS1 sponges miR‐204‐5p by acting as a ceRNA, thereby protecting RUNX2 mRNA from translation inhibition and facilitating BMSC osteogenesis. 3. Modulating IRF2 or HHAS1 can regulate BMSC osteogenic differentiation and help improve bone defect impair.
登录
查看更多内容
影响因子:
14
作者:
Lin H;Sohn J;Shen H;Langhans MT;Tuan RS
通讯作者:
Tuan RS
影响因子:
64.5
作者:
Salmena L;Poliseno L;Tay Y;Kats L;Pandolfi PP
通讯作者:
Pandolfi PP
影响因子:
9
作者:
Li, Zehan;Yan, Ming;Yu, Jinhua
通讯作者:
Yu, Jinhua
影响因子:
7.5
作者:
Infante A;Rodríguez CI
通讯作者:
Rodríguez CI
影响因子:
9
作者:
He, Shiwei;Yang, Sheng;Shuai, Cijun
通讯作者:
Shuai, Cijun